- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Новости 250 results
Press Release
июля 26, 2021
King & Spalding Bolsters Environmental, Health and Safety Bench in Austin With Addition of Suzanne Murray
Press Release
июля 8, 2021
Former Director of the CIA Gina Haspel Joins King & Spalding in Washington, D.C.
Press Release
июня 28, 2021
King & Spalding’s New York Office Adds Trials Partner David Lesser
Press Release
июня 28, 2021
King & Spalding Hires Finance Partner Benoit Lavigne in London
Press Release
июня 17, 2021
Two-Time Eastern District U.S. Attorney McGregor Scott to Join King & Spalding
Press Release
июня 7, 2021
King & Spalding LLP Partners with Russell Center to Support Black Entrepreneurs and Business Owners
Press Release
мая 20, 2021
King & Spalding Broadens Restructuring Bench in Chicago With Addition of Timothy Hoffmann
Press Release
мая 17, 2021
Government Investigations & Litigation Partner Cliff Stricklin Joins King & Spalding in Denver
Press Release
апреля 5, 2021
Firm Statement on Free and Fair Elections
Press Release
марта 29, 2021
FDA Acting Policy Director for Office of Therapeutic Biologics and Biosimilars Joins King & Spalding
Press Release
марта 19, 2021
Recent Violence Targeting Asian-Americans
Press Release
марта 16, 2021
King & Spalding Adds International Arbitration Partner Ken Beale